Approval · Notice of Compliance 348 · 2002
CAPTOPRIL TABLETS: Notice of Compliance 348
Issued August 2, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 348
- Date
- August 2, 2002
- Company
- Ivax Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Angiotensin-converting enzyme inhibitor
- Canadian reference product
- CAPOTEN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAPTOPRIL TABLETS | 02245888 | Cancelled Pre Market |
| CAPTOPRIL TABLETS | 02245891 | Cancelled Pre Market |
| CAPTOPRIL TABLETS | 02245892 | Cancelled Pre Market |
| CAPTOPRIL TABLETS | 02245893 | Cancelled Pre Market |